Evidence map›Paper›PMID 33500419›Full record

ArticleNature communications2021

The Bloom syndrome complex senses RPA-coated single-stranded DNA to restart stalled replication forks.

Ann-Marie K Shorrocks, Samuel E Jones, Kaima Tsukada, Carl A Morrow, Zoulikha Belblidia, Johanna Shen, Iolanda Vendrell, Roman Fischer, Benedikt M Kessler, Andrew N Blackford

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Anellovirus protein encoded byProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Ann-Marie K Shorrocks *MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.ORCID http://orcid.org/0000-0003-4844-1721
Samuel E Jones *MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.ORCID http://orcid.org/0000-0002-1177-2810
Kaima Tsukada *MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.ORCID http://orcid.org/0000-0002-6725-9514
Carl A Morrow *MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Zoulikha BelblidiaMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Johanna ShenMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Iolanda VendrellMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Roman FischerTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID http://orcid.org/0000-0002-9715-5951
Benedikt M KesslerTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID http://orcid.org/0000-0002-8160-2446
Andrew N BlackfordMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK. andrew.blackford@imm.ox.ac.uk.ORCID http://orcid.org/0000-0003-1979-021X
John Radcliffe Hospital · GBUniversity of Oxford · GBTokyo Institute of Technology · JP

Funding

Cancer Research UK 20772Cancer Research UK C29215/A20772Department of Health IS-BRC-1215-20008Medical Research Council G0902418Medical Research Council MC_UU_12009Medical Research Council MC_UU_12010Medical Research Council MC_UU_12025Medical Research Council MR/N013468/1Wellcome TrustWellcome Trust 107457/Z/15Z
6 · The paper itself

Abstract

The Bloom syndrome helicase BLM interacts with topoisomerase IIIα (TOP3A), RMI1 and RMI2 to form the BTR complex, which dissolves double Holliday junctions to produce non-crossover homologous recombination (HR) products. BLM also promotes DNA-end resection, restart of stalled replication forks, and processing of ultra-fine DNA bridges in mitosis. How these activities of the BTR complex are regulated in cells is still unclear. Here, we identify multiple conserved motifs within the BTR complex that interact cooperatively with the single-stranded DNA (ssDNA)-binding protein RPA. Furthermore, we demonstrate that RPA-binding is required for stable BLM recruitment to sites of DNA replication stress and for fork restart, but not for its roles in HR or mitosis. Our findings suggest a model in which the BTR complex contains the intrinsic ability to sense levels of RPA-ssDNA at replication forks, which controls BLM recruitment and activation in response to replication stress.

Indexed as

DNA ReplicationAmino Acid MotifsBloom SyndromeCRISPR-Cas SystemsDNA-Binding ProteinsDNA DamageDNA, Single-StrandedDNA Topoisomerases, Type IGene Knockdown TechniquesHeLa CellsHumansMitosisMutationProtein BindingProtein DomainsRecombinant ProteinsBloom syndrome proteinDNA-Binding ProteinsDNA, Single-StrandedDNA Topoisomerases, Type IRecombinant ProteinsRecQ HelicasesReplication Protein ARMI1 protein, humanRMI2 protein, humanTOP3A protein, human

Identifiers

PMID33500419
PMCPMC7838300
OpenAlexW3121200269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.